JP2021521178A5 - - Google Patents
Info
- Publication number
- JP2021521178A5 JP2021521178A5 JP2020555501A JP2020555501A JP2021521178A5 JP 2021521178 A5 JP2021521178 A5 JP 2021521178A5 JP 2020555501 A JP2020555501 A JP 2020555501A JP 2020555501 A JP2020555501 A JP 2020555501A JP 2021521178 A5 JP2021521178 A5 JP 2021521178A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- independently
- acceptable salt
- disease
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862655741P | 2018-04-10 | 2018-04-10 | |
| US62/655,741 | 2018-04-10 | ||
| PCT/US2019/026634 WO2019199864A1 (en) | 2018-04-10 | 2019-04-09 | Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathways |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021521178A JP2021521178A (ja) | 2021-08-26 |
| JP2021521178A5 true JP2021521178A5 (https=) | 2022-04-13 |
| JPWO2019199864A5 JPWO2019199864A5 (https=) | 2022-04-13 |
| JP7369139B2 JP7369139B2 (ja) | 2023-10-25 |
Family
ID=66248833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555501A Active JP7369139B2 (ja) | 2018-04-10 | 2019-04-09 | Ｐｉ３キナーゼおよびオートファジー経路の調節因子としての三置換アリールおよびヘテロアリール誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11492348B2 (https=) |
| EP (1) | EP3774783B1 (https=) |
| JP (1) | JP7369139B2 (https=) |
| KR (1) | KR102803762B1 (https=) |
| CN (1) | CN112189012B (https=) |
| AU (1) | AU2019251360B2 (https=) |
| EA (1) | EA202092444A1 (https=) |
| ES (1) | ES3032793T3 (https=) |
| MX (1) | MX2020010576A (https=) |
| SG (1) | SG11202008832TA (https=) |
| WO (1) | WO2019199864A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3032793T3 (en) | 2018-04-10 | 2025-07-24 | Neuropore Therapies Inc | Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathways |
| MX2021013662A (es) | 2019-05-10 | 2022-03-11 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos. |
| EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
| IL325201A (en) | 2019-06-17 | 2026-02-01 | Deciphera Pharmaceuticals Llc | Aminopyrimidine amide autophagy inhibitors and methods of using them |
| CN113121499B (zh) * | 2021-04-13 | 2022-05-31 | 海南锦瑞制药有限公司 | 奥美拉唑的合成方法及应用 |
| US12319655B2 (en) | 2021-12-09 | 2025-06-03 | Deciphera Pharmaceuticals, Llc | RAF kinase inhibitors and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| WO2008070740A1 (en) | 2006-12-07 | 2008-06-12 | F.Hoffmann-La Roche Ag | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| WO2008098058A1 (en) * | 2007-02-06 | 2008-08-14 | Novartis Ag | Pi 3-kinase inhibitors and methods of their use |
| WO2009066084A1 (en) * | 2007-11-21 | 2009-05-28 | F. Hoffmann-La Roche Ag | 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| AU2009256574A1 (en) * | 2008-06-13 | 2009-12-17 | Novartis Ag | 2,4'-bipyridinyl compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer |
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| EP2475375A4 (en) | 2009-09-09 | 2013-02-20 | Avila Therapeutics Inc | PI3 KINASE INHIBITORS AND USES THEREOF |
| EP2683243A4 (en) | 2011-03-09 | 2014-12-03 | Celgene Avilomics Res Inc | PI3 KINASE INHIBITORS AND USES THEREOF |
| ES2608967T3 (es) | 2011-03-28 | 2017-04-17 | Mei Pharma, Inc. | (Aralquilamino sustituido en alfa y heteroarilalquilamino)pirimidinil y 1,3,5-triazinil benzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para usar en el tratamiento de enfermedades proliferativas |
| RU2688665C2 (ru) * | 2014-04-22 | 2019-05-22 | Университет Базель | Новый способ получения производных триазина, пиримидина и пиридина |
| AU2015366357B2 (en) | 2014-12-17 | 2018-07-19 | Shanghai Haiyan Pharmaceutical Technology Co. Ltd. | 2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof |
| DK3416957T3 (da) | 2016-02-19 | 2020-09-21 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes |
| AU2017275657B2 (en) | 2016-06-02 | 2021-08-19 | Novartis Ag | Potassium channel modulators |
| CN112533917B (zh) | 2018-04-10 | 2024-06-21 | 神经孔疗法股份有限公司 | 作为vps34的抑制剂的吗啉衍生物 |
| ES3032793T3 (en) * | 2018-04-10 | 2025-07-24 | Neuropore Therapies Inc | Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathways |
-
2019
- 2019-04-09 ES ES19719101T patent/ES3032793T3/es active Active
- 2019-04-09 EP EP19719101.8A patent/EP3774783B1/en active Active
- 2019-04-09 AU AU2019251360A patent/AU2019251360B2/en active Active
- 2019-04-09 MX MX2020010576A patent/MX2020010576A/es unknown
- 2019-04-09 KR KR1020207032213A patent/KR102803762B1/ko active Active
- 2019-04-09 SG SG11202008832TA patent/SG11202008832TA/en unknown
- 2019-04-09 JP JP2020555501A patent/JP7369139B2/ja active Active
- 2019-04-09 EA EA202092444A patent/EA202092444A1/ru unknown
- 2019-04-09 WO PCT/US2019/026634 patent/WO2019199864A1/en not_active Ceased
- 2019-04-09 CN CN201980032054.7A patent/CN112189012B/zh active Active
- 2019-04-09 US US17/046,746 patent/US11492348B2/en active Active
-
2022
- 2022-11-07 US US17/982,425 patent/US12049462B2/en active Active
-
2024
- 2024-06-12 US US18/741,572 patent/US20240327396A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521178A5 (https=) | ||
| JP2013502431A5 (https=) | ||
| JP2018535963A5 (https=) | ||
| JP2019034943A5 (https=) | ||
| JP2018536648A5 (https=) | ||
| JP2021523200A5 (https=) | ||
| JP2012532112A5 (https=) | ||
| JP2013500314A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2013532652A5 (https=) | ||
| JP2019524883A5 (https=) | ||
| JP2012526728A5 (https=) | ||
| JP2021502387A5 (https=) | ||
| JP2011529918A5 (https=) | ||
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| JP2010523522A5 (https=) | ||
| JP2018531218A5 (https=) | ||
| JP2013542267A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| WO2018075959A4 (en) | Methods using hdac11 inhibitors | |
| JP2016503797A5 (https=) | ||
| JP2019514956A5 (https=) | ||
| JPWO2019195124A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2010538094A5 (https=) |